Generic medicine

Nirmatrelvir + Ritonavir: Brands, Price & Uses in Bangladesh

Nirmatrelvir + Ritonavir is indicated for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older and more.

Forms:COVID-19 Essentials

About Nirmatrelvir + Ritonavir

Indications of Nirmatrelvir + Ritonavir

Nirmatrelvir + Ritonavir is indicated for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older, weighing at least 40 kg) who are at high risk for progression to severe COVID-19, including hospitalization or death.

  • Established/approved use: Early treatment of confirmed SARS-CoV-2 infection, initiated as soon as possible and within 5 days of symptom onset, in high-risk patients (e.g., older age, obesity, diabetes, cardiovascular disease, chronic lung disease, immunocompromised status).
  • Not indicated for initiation of treatment in patients requiring hospitalization due to severe or critical COVID-19, and it is not a substitute for vaccination.
  • Not authorized for pre-exposure or post-exposure prevention of COVID-19, or for use longer than 5 consecutive days.

Dosage & Administration of Nirmatrelvir + Ritonavir

Standard Adult and Adolescent Dose

Renal FunctionDoseDuration
Normal to mild renal impairment (eGFR ≥ 60 mL/min)Nirmatrelvir 300 mg (two 150 mg tablets) with Ritonavir 100 mg (one tablet), taken together, twice daily5 days
Moderate renal impairment (eGFR ≥ 30 to < 60 mL/min)Nirmatrelvir 150 mg (one tablet) with Ritonavir 100 mg (one tablet), taken together, twice daily5 days
Severe renal impairment (eGFR < 30 mL/min) or severe hepatic impairmentNot recommended (insufficient data)-

All tablets in a dose of Nirmatrelvir + Ritonavir should be taken together, by mouth, with or without food, at approximately the same times each day. Treatment should begin as soon as possible after diagnosis and within 5 days of symptom onset, and should be continued for the full 5-day course even if symptoms improve.

Adherence note: Take Nirmatrelvir + Ritonavir exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice, as incomplete courses may be associated with reduced effectiveness or symptom/viral rebound.

If a dose is missed within 8 hours of the scheduled time, it should be taken as soon as possible and the regular schedule resumed; if more than 8 hours have passed, the missed dose should be skipped and the next dose taken at its regular time. Doses should not be doubled.

Side Effects of Nirmatrelvir + Ritonavir

Most reported adverse effects of Nirmatrelvir + Ritonavir are mild to moderate. Commonly reported effects include:

  • Dysgeusia (altered or metallic/bitter taste)
  • Diarrhea
  • Nausea and vomiting
  • Elevated blood pressure
  • Muscle aches (myalgia)
  • Headache

A recurrence of COVID-19 symptoms and/or a new positive test result 2-8 days after completing treatment ("viral/symptom rebound") has been reported in some patients and is generally self-limiting.

Contraindications of Nirmatrelvir + Ritonavir

Nirmatrelvir + Ritonavir is contraindicated in:

  • Patients with known hypersensitivity to nirmatrelvir, ritonavir, or any component of the formulation.
  • Patients with severe renal impairment (eGFR < 30 mL/min) or severe hepatic impairment, in whom safety and appropriate dosing have not been established.
  • Co-administration with drugs that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious or life-threatening reactions (see Interactions for examples such as certain antiarrhythmics, ergot derivatives, and certain statins).
  • Co-administration with strong CYP3A inducers where significantly reduced Nirmatrelvir + Ritonavir concentrations may lead to loss of therapeutic effect and potential development of viral resistance.

Frequently Asked Questions about Nirmatrelvir + Ritonavir

What is Nirmatrelvir + Ritonavir used for?

Nirmatrelvir + Ritonavir is used to treat mild-to-moderate COVID-19 in adults and eligible adolescents (12 years and older, weighing at least 40 kg) who are at high risk of the illness becoming severe. It must be started within 5 days of symptoms beginning.

How is Nirmatrelvir + Ritonavir taken?

Nirmatrelvir + Ritonavir is taken by mouth twice a day for 5 days. Each dose consists of two nirmatrelvir tablets and one ritonavir tablet taken together, with or without food, swallowed whole.

Can Nirmatrelvir + Ritonavir be taken with other medicines?

Nirmatrelvir + Ritonavir has a high potential for drug interactions because it contains ritonavir, a strong enzyme inhibitor. It must not be taken with certain heart rhythm medicines, certain statins, ergot medicines, and several other drug classes without a physician's review, as this can cause serious or life-threatening reactions. Always share a full list of current medicines with the prescriber before starting Nirmatrelvir + Ritonavir.

Is Nirmatrelvir + Ritonavir safe during pregnancy or breastfeeding?

Data on Nirmatrelvir + Ritonavir in pregnancy are limited, so it should only be used in pregnancy if clearly needed and the potential benefit outweighs potential risk to the fetus, as advised by a physician. Similarly, whether Nirmatrelvir + Ritonavir passes into breast milk is not well established, so a physician should be consulted to weigh the benefits of breastfeeding against the mother's need for Nirmatrelvir + Ritonavir.

What are the common side effects of Nirmatrelvir + Ritonavir?

The most commonly reported side effects of Nirmatrelvir + Ritonavir are an altered or bitter taste in the mouth, diarrhea, nausea, vomiting, elevated blood pressure, and muscle aches. Some patients also experience a return of COVID-19 symptoms or a positive test a few days after finishing Nirmatrelvir + Ritonavir ('rebound'), which is usually self-limiting.

What should I do if I miss a dose of Nirmatrelvir + Ritonavir or take too much?

If a dose of Nirmatrelvir + Ritonavir is missed and it has been less than 8 hours since it was due, take it as soon as possible and continue the normal schedule; if more than 8 hours have passed, skip the missed dose and take the next one at the usual time — do not double up. If an overdose of Nirmatrelvir + Ritonavir is suspected, seek immediate medical attention or contact a poison control center.

Disclaimer

The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.

DoctorBlogArticles